Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer-Reference-Cited by-同舟云学术

Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer

Published:2011-02-17 Issue:1 Volume:14 Page:81-90
ISSN:1436-3291
Container-title:Gastric Cancer
language:en
Short-container-title:Gastric Cancer

Author:

Imamoto Haruhiko,Oba Koji,Sakamoto Junichi,Iishi Hiroyasu,Narahara Hiroyuki,Yumiba Takeyoshi,Morimoto Takashi,Nakamura Masaki,Oriuchi Noboru,Kakutani Chieko,Morita Satoshi,Shiozaki Hitoshi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Gastroenterology,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10120-011-0016-6.pdf

Reference37 articles.

1. Mathers C. Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3:442. World Health Organization, Geneva. http://www.who.int/healthinfo/statistics/bod_projections2030_paper.pdf .

2. Glimelius B, Hoffman K, Haglund U, Nyrén O, Sjödén PO. Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol. 1994;5:189–90.

3. Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer. 1993;72:37–41.

4. Pyrhönen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer. 1995;71:587–91.

5. Ohtsu A, Boku N, Tamura F, Muro K, Shimada Y, Saigenji K, et al. A phaseII study of a 3-hour infusion of paclitaxel for advanced gastric cancer. Am J Clin Oncol. 1998;21:416.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites;Pancreatology;2024-06

2. Case Report: A rare case of recurrent ascites after anti-Claudin18.2 antibody therapy for metastatic gastric cancer while responding sustainingly;Frontiers in Oncology;2023-08-23

3. Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites;BMC Cancer;2022-02-28

4. Two Cases of Unresectable Advanced Gastric Cancer who could Resume Oral Intake following Tumor Response to Fluorouracil + folinate + oxaliplatin Therapy;Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons);2022

5. Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer;Annals of Surgical Oncology;2021-10-05